Just reading about the top SH and director of IRM David Zohar's plan to remove both Keith Whitehouse and John Watts from their directorships. Does anyone know anymore about this??
Although the delay in assay results from Blythe doesnt please me, it isnt a company specific problem. I would like to know more about Robert Sebek and why DZ thinks he will perform better? Times like this make me wish I knew what was going on behind closed doors!
